CERS

Cerus Corporation

Price

$2.85

return (12m)

139.50%

p/e

-86.86

p/bv

8.33

DIVIDEND YIELD

0.00%

CERS price

Cerus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CERS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.52%

3 months

4.01%

1 year

139.50%

2 years

22.32%

5 years

-51.61%

10 years

-58.64%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CERS

Valuation

P/E

-86.86

Sector -2.19

Industry 1.21

P/BV

8.33

Sector 2.22

Industry 2.11

P/Revenue (PSR)

2.66

Sector 2.01

Industry 0.78

EV/EBITDA

-799.30

Sector -17.81

Industry -25.30

EV/EBIT

-485.04

Sector -26.72

Industry -18.04

P/EBITDA

202.38

Sector 0.36

Industry 0.18

P/EBIT

478.80

Sector -3.34

Industry 1.26

P/Total Assets

2.87

Sector 1.23

Industry 0.86

P/Net Current Assets

25.79

Sector -27.35

Industry -12.37

P/Working Capital

8.23

Sector -4.54

Industry -49.48

EPS

-0.03

Sector -0.87

Industry -0.55

BVPS

0.35

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

52.05%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-1.24%

Sector -323.65%

Industry -73.39%

EBIT Margin

-2.04%

Sector -194.57%

Industry -11.94%

Operating Margin

-0.73%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-3.06%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.28

Sector 0.12

Industry 0.22

Profitability

ROE

-9.59%

Sector -33.82%

Industry -37.56%

ROA

-3.30%

Sector -29.63%

Industry -17.56%

ROIC

-6.58%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.83

Sector 1.84

Industry 1.14

Net Debt / EBITDA

30.18

Sector -1.47

Industry -31.86

Net Debt / EBIT

18.32

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.30

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.49

Sector 0.14

Industry 0.51

Equity/Assets

0.34

Sector 0.42

Industry 0.25

Liabilities/Assets

0.66

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

11.10%

Sector -

Industry -

5Y Earnings CAGR

-34.06%

Sector -

Industry -

Fundamentals CERS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CERS Cerus Corporation	$2.85	128.00%	0.00%	-86.86	8.33	-9.59%	-3.06%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CERS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cerus

Cerus Corporation

Average Investor10 user rating

4.0 (0 people)

United States

35 years

Founded: 1991

1997

Time since IPO - 29 years

270

Employees

Cerus Corporation (United States) is listed on the Nasdaq and has a market capitalization of $588.93 million, with shareholders equity totaling $70.72 million.

The company employs approximately 270 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Cerus Corporation reported $221.55 million in revenue, generating net income of $-6.78 million.

Key financial metrics include a P/E ratio of -86.86, a price-to-book (P/B) ratio of 8.33, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CERS.

Market cap

$588.93 million

Net worth

$70.72 million

$70,720,000.00

Assets

$205.19 million

$205,190,000.00

Total Shares Outstanding

201.00 million

201,000,000

Average Daily Trading Volume

$2.83 million

$2,833,042.74

Sector

Health

Industry

Medical Supplies and Equipment

CERS

CERS revenue and profits

Financial Results CERS

DRAG THE FRAME TO SEE MORE DATA

CERS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87